Medication info

Nunasporin Tablets

Prescription medicationExpired
Ingredient · strength
Ranitidine Hydrochloride›Strength being verifiedSucralfate Hydrate›Strength being verifiedTripotassium Bismuth Dicitrate›Strength being verified
Manufacturer / importer
AhnKook NewPharm Co., Ltd.
Appearance
Green round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201801100 · Approved 2018.03.09

This product's status changed to Expired on 2023.03.09. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., gastric ulcer and reflux esophagitis); prevention of Mendelson syndrome
Who uses it
Adults
Adult dosage
○ Adults Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, with or without food. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate can be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and at bedtime. The dosage is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant treatment to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets once daily at bedtime. However, in patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets per dose 3 times daily as the starting dose, and increase as necessary. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets per dose on the night before surgery.

Ingredients

Manufacturer
AhnKook NewPharm Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., gastric ulcer and reflux esophagitis); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
  • gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs
View approved original text

This medication is used to treat gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also helpful in preventing post-surgical ulcers and treating gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs. It may be administered before anesthesia to prevent Mendelson's syndrome. This medication suppresses gastric acid secretion, protects the gastric mucosa, and is effective in alleviating symptoms. It is widely used for various gastrointestinal disorders.

Dosage and Administration

Adult dosage

○ Adults Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, with or without food. 1) Gastric and duodenal ulcers Administer 2 tablets per dose twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate can be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and at bedtime. The dosage is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant treatment to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets once daily at bedtime. However, in patients with severe reflux esophagitis, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets per dose 3 times daily as the starting dose, and increase as necessary. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. It is also preferable to administer 2 tablets per dose on the night before surgery.

Precautions

This medication should not be administered to patients undergoing dialysis or those with kidney function impairments. Additionally, it should be avoided in patients with a history of allergic reactions to this medication or its components, those with acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or women who may become pregnant, premature infants and newborns, and patients on potassium-restricted diets. Patients with impaired liver function or a history of drug allergies, elderly patients, those with a history of kidney function abnormalities, and patients taking non-steroidal anti-inflammatory drugs should use this medication cautiously; especially, middle-aged individuals with gastric cancer symptoms should confirm malignancy before use, as this medication can mask such symptoms. Patients with Helicobacter pylori infection who have gastric and duodenal ulcers require bacterial eradication efforts, and severe ICU patients or patients with hypophosphatemia also need special caution. While taking this medication, rare reactions like anaphylactic shock, skin rashes, hives, angioedema, and respiratory distress may occur; in such cases, usage should be discontinued immediately and healthcare professionals consulted. Blood tests have reported leukopenia, thrombocytopenia, abnormal liver function, arrhythmias, gastrointestinal disorders, and neuropsychiatric symptoms; if any of these occur, please inform healthcare professionals immediately. Long-term use should be avoided, and regular checks for blood, liver, and kidney function should be done during treatment. Particularly, elderly patients or those with chronic lung diseases, diabetes, and weakened immunity may have an increased risk of pneumonia, so caution is necessary. If dizziness or drowsiness occurs, avoid driving or operating hazardous machinery. This medication may interact with other drugs, so consult healthcare professionals, especially when taking anticoagulants, antibiotics, anticonvulsants, etc.; some medications may require spacing out their administration. Pregnant or breastfeeding women should not use this medication, and it is not recommended for children as safety and efficacy are not established. In cases of overdose, treatments such as vomiting or gastric lavage may be needed, and in severe cases, blood dialysis may be necessary to remove the drug. This medication reduces gastric acid secretion, which may promote bacterial growth in the stomach; therefore, eye examinations may be necessary during long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 55 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST·ALT·r-GTP·ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • convulsion
  • agitation
  • insomnia
  • headache
  • feeling of heaviness in the head
  • illness feeling
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorder
  • disturbance of consciousness
  • hypertrophic muscle cramps
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • mild erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture, ideally at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

Green round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.